GoldenGolden
New Haven Pharmaceuticals

New Haven Pharmaceuticals

A pharmaceutical company developing drugs to treat cardiovascular disease

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

October 29, 2012
New Haven Pharmaceuticals raises a $6,000,000 series A round from Advantage Capital Partners, Connecticut Innovations and Kuzari.

Funding rounds

People

Name
Role
LinkedIn

Brad LeBlanc

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.